NDC Directory Finished Products
Table of FINISHED Products
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | RxNorm | Status | |
|---|---|---|---|---|---|---|---|---|
| 0069-0232 | Fragmin | Dalteparin Sodium | Injection | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0234 | Propofol | Propofol | Injection, Emulsion | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0235 | Cibinqo | Abrocitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0238 | Ruxience | Rituximab-pvvr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0242 | Toviaz | Fesoterodine Fumarate | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0244 | Toviaz | Fesoterodine Fumarate | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0248 | Propofol | Propofol | Injection, Emulsion | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0249 | Ruxience | Rituximab-pvvr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0251 | Xalkori | Crizotinib | Capsule, Coated Pellets | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0253 | Fragmin | Dalteparin Sodium | Injection | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0274 | Velsipity | Etrasimod | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0284 | Ibrance | Palbociclib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0291 | Nivestym | Filgrastim-aafi | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0292 | Nivestym | Filgrastim-aafi | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0293 | Nivestym | Filgrastim-aafi | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0294 | Nivestym | Filgrastim-aafi | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0296 | Talzenna | Talazoparib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0297 | Ticovac | Tick-borne Encephalitis Vaccine | Injection | Intramuscular | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0298 | Daurismo | Glasdegib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0305 | Trazimera | Trastuzumab-qyyp | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0308 | Trazimera | Trastuzumab-qyyp | Injection, Powder, Lyophilized, For Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0315 | Zirabev | Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0324 | Nyvepria | Pegfilgrastim-apgf | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0325 | Abrilada | Adalimumab-afzb | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0328 | Abrilada | Adalimumab-afzb | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0333 | Abrilada | Adalimumab-afzb | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0334 | Litfulo | Ritlecitinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0335 | Cibinqo | Abrocitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0336 | Revatio | Sildenafil Citrate | Powder, For Suspension | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0338 | Revatio | Sildenafil Citrate | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0342 | Zirabev | Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0344 | Abrysvo | Respiratory Syncytial Virus Vaccine | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0400 | Zithromax | Azithromycin Dihydrate | Injection, Powder, Lyophilized, For Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0411 | Ticovac | Tick-borne Encephalitis Vaccine | Injection | Intramuscular | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0435 | Cibinqo | Abrocitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0468 | Chantix | Varenicline Tartrate | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0469 | Chantix | Varenicline Tartrate | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0471 | Chantix | Varenicline Tartrate | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0486 | Ibrance | Palbociclib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0501 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0502 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0504 | Bosulif | Bosutinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0505 | Ngenla | Somatrogon-ghla | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0507 | Xalkori | Crizotinib | Capsule, Coated Pellets | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0520 | Ngenla | Somatrogon-ghla | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0550 | Sutent | Sunitinib Malate | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0600 | Penbraya | Meningococcal Groups A, B, C, W, And Y Vaccine | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |||
| 0069-0688 | Ibrance | Palbociclib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0770 | Sutent | Sunitinib Malate | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0809 | Inflectra | Infliximab-dyyb | Injection, Powder, Lyophilized, For Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0830 | Sutent | Sunitinib Malate | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0950 | Vibramycin Hyclate | Doxycycline Hyclate | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0970 | Vibramycin Monohydrate | Doxycycline | Powder, For Suspension | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0971 | Vibramycin Calcium | Doxycycline Calcium | Syrup | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-0980 | Sutent | Sunitinib Malate | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1001 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1002 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1011 | Panzyga | Immune Globulin Intravenous (human) | Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1014 | Bosulif | Bosutinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1029 | Xeljanz | Tofacitinib | Solution | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1031 | Talzenna | Talazoparib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1061 | Cutaquig | Immunoglobulin G | Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1109 | Panzyga | Immune Globulin Intravenous (human) | Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1195 | Talzenna | Talazoparib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1198 | Vizimpro | Dacomitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1224 | Panzyga | Immune Globulin Intravenous (human) | Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1235 | Talzenna | Talazoparib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1305 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1306 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1307 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1308 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1309 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1311 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1312 | Panzyga | Immune Globulin Intravenous (human) | Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1318 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1415 | Panzyga | Immune Globulin Intravenous (human) | Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1476 | Cutaquig | Immunoglobulin G | Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1500 | Xalkori | Crizotinib | Capsule, Coated Pellets | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1501 | Talzenna | Talazoparib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1509 | Cutaquig | Immunoglobulin G | Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1520 | Norvasc | Amlodipine Besylate | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1530 | Norvasc | Amlodipine Besylate | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1531 | Daurismo | Glasdegib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1540 | Norvasc | Amlodipine Besylate | Tablet | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1558 | Panzyga | Immune Globulin Intravenous (human) | Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1751 | Talzenna | Talazoparib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1802 | Cutaquig | Immunoglobulin G | Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1960 | Cutaquig | Immunoglobulin G | Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1965 | Cutaquig | Immunoglobulin G | Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-1975 | Vyndaqel | Tafamidis Meglumine | Capsule, Liquid Filled | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2150 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2160 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2170 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2180 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2190 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2250 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2260 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2270 | Caduet | Amlodipine Besylate And Atorvastatin Calcium | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2299 | Vizimpro | Dacomitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
| 0069-2362 | Comirnaty | Covid-19 Vaccine, Mrna | Injection, Suspension | Intramuscular | Pfizer Laboratories Div Pfizer Inc | ACTIVE |
TOTAL FINISHED PRODUCTS: 109,681
TOTAL FINISHED PRODUCTS BY TYPE
HUMAN OTC DRUG PRODUCTS: 53,980
HUMAN PRESCRIPTION DRUG PRODUCTS: 53,048
NON-STANDARDIZED ALLERGENIC PRODUCTS: 2,044
PLASMA DERIVATIVE PRODUCTS: 320
VACCINE PRODUCTS: 141
STANDARDIZED ALLERGENIC PRODUCTS: 126
CELLULAR THERAPY PRODUCTS: 22